ULVAC-PHI - China

China
Time frame: 1 August 2024 - 31 July 2025

Profile

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides absolute Count of primary research articles and fractional Share counts of author contribution to articles. The positions in the table below reflect ULVAC-PHI - China's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where ULVAC-PHI - China is listed.

Position by research output Share

China
Corporate 409

Position by research output Share in subject areas

China
Chemistry 940

Research

ULVAC-PHI - China has the following research output in the current window (1 August 2024 - 31 July 2025) of the Nature Index. Click on Count to view a list of articles representing the corresponding Share value.

Overall research output

Count Share
Overall 2 0.16

Overall Count and Share for 'ULVAC-PHI - China' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Chemistry 2 0.16

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs.

Note: Hover over the donut graph to view the Share for each subject.

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Get Started

Green Energy

Powering the Future: Research Insights for a Sustainable Energy Transition
Read more

Job finder

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active job seekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

  • Advertisement

Latest supplement

Nature Index 2025 Immunology

Advanced tools are giving researchers unprecedented insight into the human immune system. But progress in immunology — including vaccine development — is under threat from funding cuts and other challenges. As cases of infectious diseases such as measles and tuberculosis increase, researchers are racing to develop solutions that can protect vulnerable populations and preserve hard-won gains.

Nature Index 2025 Immunology
Access free

Relationships

Affiliated institutions

The following affiliated institutions are wholly owned, operated, administered or contains research facilities for ULVAC-PHI - China. All affiliations for an affiliated institution are credited to the institution to which it is affiliated. Each of the affiliated institutions listed below has its own research profile.